Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites

M Hull1, A Beane, J Bowen

  • 1Division of Medicine, St James's University Hospital, Leeds, UK. medmah@stjames.leeds.ac.uk

Abstract

Insights

Naso-pharyngeal methicillin-resistant Staphylococcus aureus colonization predicts peristomal infection after gastrostomy. Current antibiotic prophylaxis may be ineffective against this pathogen.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Antibiotic prophylaxis for percutaneous endoscopic gastrostomy (PEG) insertion is debated.
  • The microbiology of PEG site infections is understudied, impacting prophylaxis choices.

Purpose of the Study:

  • Investigate peristomal infection bacteriology after PEG insertion.
  • Determine the role of methicillin-resistant Staphylococcus aureus (MRSA) in these infections.

Main Methods:

  • Collected nasal and pharyngeal swabs from patients before PEG insertion.
  • Prospectively monitored peristomal colonization and infection at 2-3 and 7 days post-insertion.

Main Results:

  • 31 patients underwent PEG insertion; 35% had MRSA naso-pharyngeal colonization.
  • MRSA colonization invariably led to peristomal colonization.
  • Peristomal infection occurred in 26% of cases, with 88% being MRSA-positive.
  • Naso-pharyngeal MRSA colonization significantly increased peristomal infection risk (OR 10.8).

Conclusions:

  • Naso-pharyngeal MRSA colonization predicts peristomal MRSA colonization and infection post-PEG.
  • Standard antibiotic prophylaxis may be inadequate in areas with high MRSA rates.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...